Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-23

Here is an extract from Prostate cancer results stating the detection is working both through MRI & MRX.

MRX detection is being done in the lab in US, expecting that to be successful. I personally feel MRI functional image is better outcome as it is a quicker path to commercialisation and easier to scale up. Waiting in excitement for some results showing efficacy.




“The preclinical research being presented provides strong evidence that the Company’s magnetic nanoparticle technology has the potential to target prstate cancer tumours expressing the Prostate Specific Membrane Antigen (PSMA) with high specificity, accumulating preferentially in tissues expressing PSMA and not in other vital organs. Importantly, the research shows the imaging agent is detectable by both MRI and the Company’s proprietary magnetic relaxometry technology. The data being presented follow from the initial work supported by a CSIRO Innovations Connections grant. Further studies will be needed to substantiate the imaging agent’s ability to detect clinically significant disease.”